{"schema_version":"secwatch.filing_event.v1","accession":"0001663577-26-000218","form_type":"8-K","ticker":"BPTH","cik":"0001133818","company_name":"BIO-PATH HOLDINGS, INC.","filed_at":"2026-07-16T17:56:43+00:00","discovered_at":"2026-07-16T17:58:00.485150+00:00","generated_at":"2026-07-16T17:58:20.951197+00:00","sec_items":["3.02","5.03","7.1","8.1"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bio-Path pivots to crypto treasury, signs LOI with altFINS, and engages Farrington for biotech asset sale","bullets":["Raised $28,659 from Reg A sales of 955,300 shares; authorized 5M Series B Preferred shares convertible into 1,000 common each.","MD Anderson agreed to restart Phase 2 AML trials if Bio-Path pays $292,264 (BP1001) and $63,287 (BP1002) past due.","Issued 22,342 Series B Preferred for Himalaya Technologies (OTC: HMLA) valued at $670,260, making HMLA a majority-owned subsidiary.","Engaged Farrington Capital for exclusive out-license/asset sale of DNAbilize platform and all drug programs; 60-day exclusivity.","Signed LOI with altFINS for Gen2 digital asset treasury; altFINS to receive 2.5M BPTH shares, BPTH gets option to invest €2M at €7.4M valuation."],"urls":{"canonical":"https://secwatch.observer/filing/0001663577-26-000218","json":"https://secwatch.observer/filing/0001663577-26-000218.json","markdown":"https://secwatch.observer/filing/0001663577-26-000218.md","text":"https://secwatch.observer/filing/0001663577-26-000218.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133818/000166357726000218/0001663577-26-000218-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133818/000166357726000218/bpth_8k071626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T17:58:20.951197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}